Skip to content

Pharma.Tips

Unlocking Pharma's Secrets: Your Ultimate Guide to Pharmaceutical Success!

  • Home
  • About Us
  • Contact

Deviation Case Studies

  • Home
  • Deviation Case Studies
  • Page 21

Audit trail deletion identified during internal audit – 483 observation breakdown

Symptoms of the audit trail deletion became evident during the routine internal audit when it was detected that some batch records were missing data entries in their audit trails. Specific…

Audit trail deletion identified during data review – remediation failure analysis

The issue emerged during a scheduled internal data review, wherein discrepancies were noted between recorded batch production data and the electronic batch record (EBR). It was found that audit trails…

Expired material issued to production during distribution – CAPA failure explained

The identification of the use of expired materials often begins with observable symptoms on the production floor. In this case, the following signals indicated a potential deviation:Click to read the…

Temperature excursion not assessed during material storage – CAPA failure explained

In this scenario, several symptoms indicated that a temperature excursion had potentially occurred:Click to read the full article.

Excursion trend ignored during inspection – product quality impact case study

The initial signals of the excursion trend emerged subtly over weeks, manifesting as minor fluctuations in temperature and humidity readings in the warehouse where critical raw materials were stored. Although…

Excursion trend ignored during material storage – product quality impact case study

The incident began with multiple reports from the Quality Control (QC) laboratory where analysis of API batches revealed impurities and a reduced potency compared to historical data. Specifically, the laboratory…

Cold chain monitoring failure during inspection – product quality impact case study

The failure of cold chain monitoring often manifests through various symptoms, which might not be immediately apparent. During a routine inspection, the following signals were identified:Click to read the full…

FEFO not followed during distribution – product quality impact case study

The initial signs of the failure to follow FEFO practices became evident during routine checks in the warehouse. Quality Control (QC) staff noted discrepancies in product expiration dates and inventory…

Excursion trend ignored during material storage – CAPA failure explained

The first indication of a potential issue was raised during routine temperature monitoring of the warehouse materials. The temperature data, collected via automated sensors, revealed a worrying trend: over the…

Excursion trend ignored during warehouse audit – inspection citation analysis

The first signs of trouble were identified during a routine warehouse audit. Quality Control (QC) personnel noted discrepancies in environmental monitoring logs for temperature-sensitive materials stored in the warehouse. Key…

FEFO not followed during warehouse audit – inspection citation analysis

The first indicator of FEFO non-compliance was reported during a routine warehouse audit. Observations included:Click to read the full article.

Excursion trend ignored during distribution – inspection citation analysis

Realizing that an excursion trend has been ignored often starts with observing symptoms on the production floor or in the laboratory. Common indicators include:Click to read the full article.

Posts pagination

Previous 1 … 20 21 22 … 25 Next

Quick Guide

  • Dosage Forms & Drug Delivery Systems
    • Solid Oral Dosage Forms (Tablets, Capsules)
    • Liquid Oral Dosage Forms (Syrups, Suspensions)
    • Parenteral Dosage Forms (Injectables)
    • Topical & Dermatological Dosage Forms
    • Ophthalmic Dosage Forms
    • Otic Dosage Forms
    • Inhalation & Nasal Dosage Forms
    • Transdermal Drug Delivery Systems
    • Rectal & Vaginal Dosage Forms
    • Dental Dosage Forms
    • Aerosol Formulations
    • Advanced & Novel Drug Delivery Systems
    • Miscellaneous / Combination Drug Products
  • Product Types & Therapeutic Categories
    • Active Pharmaceutical Ingredients (APIs)
    • Finished Pharmaceutical Products (FPPs)
    • Biologics
    • Biosimilars
    • Advanced Therapy Medicinal Products (ATMPs)
    • Oncology Products
    • Hormonal Products
    • Orphan Drugs
    • Radiopharmaceuticals
    • Controlled Substances & Schedule Drugs
    • Ophthalmic & Otic Products
    • Veterinary Medicines
    • Medical Devices
    • Nutraceuticals & Dietary Supplements
    • Herbal & Ayurvedic Products
    • Cosmetic & Cosmeceutical Products
  • Manufacturing Defects & Product Failures
    • Tablet Manufacturing Defects
    • Capsule Manufacturing Defects
    • Injectable Product Defects
    • Ointment & Cream Defects
    • Suspension & Syrup Defects
    • Dry Powder Inhaler (DPI) Defects
    • Transdermal Patch Defects
    • Primary Packaging Defects
    • Secondary & Tertiary Packaging Defects
    • Stability-Induced Product Defects
  • Deviation & Failure Case Studies
    • Manufacturing Deviation Case Studies
    • QC Laboratory Deviations
    • Environmental Monitoring Deviations
    • Sterility & Contamination Deviations
    • Data Integrity Breach Case Studies
    • Validation & Qualification Deviations
    • Warehouse & Storage Deviations
    • Packaging & Labeling Deviations
    • Cleaning & Cross-Contamination Deviations
    • Training & Documentation Deviations
  • Equipment & Instrumentation Troubleshooting
    • Tablet Compression Machine Issues
    • Capsule Filling Machine Issues
    • Granulation Equipment (FBD, RMG) Issues
    • Coating Equipment Problems
    • Filling Line Equipment Problems
    • Autoclave & Depyrogenation Tunnel Issues
    • Blister & Cartoning Machine Issues
    • Labeling & Printing Machine Faults
    • HPLC / GC / UHPLC Equipment Faults
    • HVAC & Cleanroom Troubleshooting
  • Process Optimization & Manufacturing Excellence
    • Compression Process Optimization
    • Granulation Process Optimization
    • Blending Uniformity Improvement
    • Capsule Filling Optimization
    • Solution & Suspension Preparation Optimization
    • Sterile Filtration & Filling Optimization
    • Drying Process Optimization (FBD, Tray Dryer)
    • Coating Efficiency & Uniformity
    • Yield Improvement Strategies
    • Cleaning Cycle Time Reduction
  • Functional Areas in Pharma Operations
    • Manufacturing & Production
    • Quality Assurance (QA)
    • Quality Control (QC)
    • Regulatory Affairs
    • Research & Development (R&D)
    • Validation & Qualification
    • Engineering & Maintenance
    • Packaging Development
    • Stability Studies
    • Supply Chain & Logistics
    • Clinical & Pharmacovigilance
    • Information Technology (IT)
    • Environment, Health & Safety (EHS)
    • Training & HR in GMP Environment
    • Intellectual Property Management (IPR)
    • Project Management
    • Corporate Compliance & Audit Readiness
  • Regulatory Compliance & Quality Systems
    • Good Manufacturing Practices (GMP)
    • WHO GMP Compliance
    • WHO Prequalification (PQ)
    • Good Laboratory Practices (GLP)
    • Good Clinical Practices (GCP)
    • Good Documentation Practices (GDP / ALCOA+)
    • Data Integrity Compliance
    • Validation & Qualification Compliance
    • Audit Readiness & Regulatory Inspections
    • Electronic Records & Electronic Signatures (ERES)
    • Quality Management System (QMS)
    • Regulatory Submissions & Dossiers
    • Serialization & Traceability
    • Import / Export Regulatory Compliance
    • Environmental, Health & Safety Regulations
    • ICH Guidelines & Global Frameworks
    • Controlled Substances Regulations
    • Medical Device Regulatory Compliance
  • Pharmaceutical Research & Drug Development
    • Drug Discovery
    • Preclinical Research
    • Pharmaceutical Research Methodologies
    • Formulation Development
    • Process Development
    • Scale-Up & Tech Transfer
  • Raw Materials & Excipients Management
    • API Quality & Variability Issues
    • Excipient Selection & Compatibility
    • Vendor Qualification & Audits
    • Raw Material Sampling Errors
    • Material Storage & Shelf-Life Control
    • Change Management for Raw Materials
    • Pharmacopoeial Compliance (USP/EP/IP)
    • Material Traceability & Mix-Up Prevention
    • Nitrosamine Risk in Raw Materials
  • Pharmaceutical Packaging Systems
    • Primary Packaging Material Selection
    • Container Closure Integrity (CCI)
    • Blister vs Bottle Packaging Decisions
    • Extractables & Leachables (E&L)
    • Child-Resistant & Senior-Friendly Packaging
    • Cold Chain Packaging Systems
    • Packaging for Sterile Products
    • Artwork Control & Regulatory Review
    • Packaging Line Design & Scale-Up
  • Cleaning, Contamination & Cross-Contamination Control
    • Cleaning Validation Fundamentals
    • Worst-Case Product Selection
    • Residue Limit Calculations (MACO)
    • Detergent Selection & Residue Control
    • Campaign Manufacturing Risks
    • Shared Facility Risk Management
    • Visual Inspection Failures
    • Swab vs Rinse Sampling Issues
    • Cleaning Deviations & CAPA
  • Data Integrity & Digital Pharma Operations
    • ALCOA+ Principles Explained Practically
    • Audit Trail Review Failures
    • Spreadsheet & Excel Data Integrity
    • LIMS Data Integrity Issues
    • CDS (Chromatography Data System) Risks
    • User Access & Privilege Control
    • Backup, Archival & Data Retention
    • Hybrid Paper–Electronic Systems
    • Data Integrity During Inspections
  • Validation, Qualification & Lifecycle Management
    • Process Validation Stage 1–3
    • Continued Process Verification (CPV)
    • Equipment Qualification Pitfalls
    • Utility Qualification (PW, WFI, HVAC)
    • Cleaning Validation Lifecycle
    • Analytical Method Validation Errors
    • Computer System Validation (CSV/CSA)
    • Revalidation Triggers & Strategy
    • Validation Documentation Best Practices
  • Stability Studies & Shelf-Life Management
    • Stability Study Design Errors
    • OOT & OOS in Stability Studies
    • Climatic Zone Considerations
    • Bracketing & Matrixing Misuse
    • Photostability Study Failures
    • Stability Trending & Statistical Analysis
    • Label Claim Justification
    • Ongoing Stability Program Gaps
    • Regulatory Expectations for Stability
  • Pharmaceutical Quality Systems (Advanced QMS)
    • QMS Design for GMP Compliance
    • Management Review Effectiveness
    • Quality Risk Management (ICH Q9)
    • Change Control System Failures
    • CAPA System Effectiveness
    • Deviation Trending & Metrics
    • Supplier Quality Management
    • Document Control System Design
    • Inspection Readiness Programs
  • Regulatory Inspections & Enforcement Actions
    • FDA Inspection Types & Strategy
    • Form 483 Observations Explained
    • Warning Letter Case Studies
    • Data Integrity Enforcement Trends
    • Consent Decrees & Import Alerts
    • Inspection Preparation Checklists
    • Inspector Interview Handling
    • Mock Audit Execution
    • Post-Inspection Remediation
  • Pharmaceutical Manufacturing Scale-Up & Tech Transfer
    • Lab to Pilot Scale Challenges
    • Pilot to Commercial Scale Risks
    • Tech Transfer Documentation
    • CMOs & CDMOs Tech Transfer
    • Process Robustness at Scale
    • Equipment Equivalency Issues
    • Site-to-Site Transfer Risks
    • Regulatory Filing Impact of Scale-Up
    • Post-Approval Change Management
  • Human Factors, Training & GMP Culture
    • GMP Training Effectiveness
    • Human Error in Manufacturing
    • SOP Design & Usability
    • Shift Handover Failures
    • Operator Qualification Programs
    • Training Documentation Gaps
    • Behavioral GMP Issues
    • Quality Culture Development
    • Management Accountability in GMP
  • Pharmaceutical Engineering & Utilities
    • HVAC Design for GMP Facilities
    • Cleanroom Classification Errors
    • Water Systems (PW/WFI) Issues
    • Compressed Air & Gas Quality
    • Preventive Maintenance Failures
    • Calibration System Weaknesses
    • Facility Layout & Material Flow
    • Utility Excursion Management
    • Engineering Change Control
  • Supply Chain, Warehousing & Distribution
    • GDP for Warehousing
    • Temperature Excursion Management
    • Cold Chain Failures
    • Distribution Qualification
    • Third-Party Logistics Oversight
    • Recall Readiness & Traceability
    • Serialization & Track-and-Trace
    • Import Export Compliance Issues
    • Warehouse Audit Findings
  • Pharma Audits, Risk & Compliance Strategy
    • Internal Audit Program Design
    • Risk-Based Audit Planning
    • Vendor & CMO Audits
    • Audit Observation Classification
    • Audit Response Writing
    • CAPA Risk Prioritization
    • Regulatory Intelligence & Trends
    • Compliance Governance Models
    • Corporate Quality Strategy
  • Emerging Technologies & Future Pharma Operations
    • Continuous Manufacturing
    • PAT & Real-Time Release Testing
    • AI & Automation in Pharma
    • Digital Twins in Manufacturing
    • Paperless GMP Systems
    • Advanced Analytics for Quality
    • Smart Factories & Pharma 4.0
    • Regulatory View on New Technologies
Copyright © 2026 Pharma.Tips Theme: Timely News By Artify Themes.